Analysis Chemical Thank You Senate hearing on hazardous substance listing for PFAS finds common ground, but disagreements on implementation tactics
Agency IQ
MARCH 25, 2024
The testimony of witnesses and the Senators themselves largely agreed on the designation, but diverged on questions of liability exemptions. high cholesterol, changes in liver enzymes, decreased immune response to vaccination, thyroid disorders, and cancer). The hearing also featured questions from BEN CARDIN (D-Md.),
Let's personalize your content